Damian Tolan
Papers
1
Total Citations
29
H-Index
1
About
Damian Tolan is a leading clinical researcher in colorectal surgery, whose work has significantly advanced the safety of rectal cancer procedures. His primary research focuses on preventing anastomotic leaks—a severe complication following bowel resection—through the innovative use of intraoperative fluorescence angiography. Tolan is best known as the principal investigator of the landmark IntAct trial, an unblinded randomised controlled trial published in 2025 that rigorously tested the efficacy of indocyanine green (ICG) fluorescence angiography. This study, which has already garnered 29 citations, provided critical evidence on how real-time vascular assessment during surgery can reduce leak rates, directly influencing surgical protocols worldwide. Beyond this pivotal trial, his contributions have shaped best practices in minimally invasive and oncologic colorectal surgery. With a career dedicated to translating imaging technology into tangible patient outcomes, Tolan’s work stands as a cornerstone in the effort to make rectal cancer surgery safer, earning him recognition as a key figure in evidence-based surgical innovation.
Research Focus
Key Achievements
Top Papers
- 1